Treatment of lung cancer with a nitrobenzamide compound in combination with a growth factor inhibitor

Details for Australian Patent Application No. 2010210636 (hide)

Owner Bipar Sciences, Inc.

Inventors Sherman, Barry M.; Bradley, Charles; Ossovskaya, Valeria S.

Agent A J Park

Pub. Number AU-A-2010210636

PCT Pub. Number WO2010/091140

Priority 61/149,977 04.02.09 US

Filing date 4 February 2010

Wipo publication date 12 August 2010

International Classifications

A01N 47/28 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid - Ureas or thioureas containing the groups NCON or NCSN

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

Event Publications

15 September 2011 Amendment Made

  The nature of the amendment is: Amend the invention title to read Treatment of lung cancer with a nitrobenzamide compound in combination with a growth factor inhibitor

22 September 2011 PCT application entered the National Phase

  PCT publication WO2010/091140 Priority application(s): WO2010/091140

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010210639-Server-side support for seamless rewind and playback of video streaming

2010210627-Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin -5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate